Byline: Date Only
Seven Faculty of Medicine students win prestigious Vanier Canada Scholarships
By Patricia Angel | August 31, 2012
Seven doctoral students in the UBC Faculty of Medicine have received Vanier Canada Graduate Scholarships from the Government of Canada. Vanier scholars receive $50,000 annually for up to three years to support their graduate studies in the social sciences, humanities, natural sciences, engineering or health sciences. The Faculty of Medicine’s 2012 Vanier Scholars and their […]
UBC leads the way in using new technologies to train future doctors
By Patricia Angel | August 28, 2012
New tools, including simulation labs and virtual patients, provide valuable hands-on training for medical students.
InterCultural Online Network receives funding to help prevent and manage diabetes in BC’s multicultural rural communities
By Patricia Angel | August 13, 2012
The project will establish a peer-support diabetes program.
The medical dimension of the Olympics
By bkladko | August 13, 2012
Faculty members Jack Taunton and Robert McCormack share their first-hand insights with the CMAJ.
Working to protect Olympic athletes from injuries
By bkladko | July 30, 2012
Babak Shadgan, a postdoctoral research fellow, aims to develop evidence-based recommendations for wrestling and other sports.
Psychiatry resident uses soccer to help at-risk individuals
By bkladko | July 27, 2012
Dr. Bates has taken some of his players to competitions in Rio de Janeiro and Paris.
Four new appointments to Faculty’s leadership
By Patricia Angel | July 24, 2012
Frederick Mikelberg, Professor in the Dept. of Ophthalmology & Visual Sciences, is the new Vice-Dean, Academic Affairs.
Evan Wood, Julio Montaner send message to President Obama, Mitt Romney
By bkladko | July 23, 2012
Dr. Wood, a Clinical Associate Professor, was interviewed by the CBC about an advertising campaign decrying the war on drugs.
Severe flu increases risk of Parkinson’s
By bkladko | July 20, 2012
The epidemiological study also found that having red measles in childhood lowered the odds of developing the disease.
Widely-used MS drug doesn’t measurably slow progression of the disease, researchers find
By bkladko | July 18, 2012
The study, by Associate Professor of Neurology Helen Tremlett and others, examined the effectiveness of beta-interferons.